Search for: "Aparajita Lath" Results 1 - 17 of 17
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Feb 2023, 10:28 am by alath
By Aparajita Lath In January, the Federal Trade Commission (FTC) released a new draft rule that would categorically ban non-compete clauses — contractual terms between an employer and an employee that prevent subsequent employment at a competing firm — across the country. [read post]
12 Jan 2023, 8:14 am by alath
By Aparajita Lath Last month, the patent battle between COVID-19 mRNA vaccine manufacturers continued with BioNTech/Pfizer filing a strong defense and counter-claim to Moderna’s allegations of patent infringement. [read post]
22 Nov 2022, 8:43 am by alath
By Aparajita Lath The future of public health in an “RNA world” is on trial in a trade secrecy dispute worth $950 million currently being fought before the District Court of the Western District of Washington, Seattle between HDT Bio Corp. and Emcure Pharmaceuticals. [read post]
18 Nov 2022, 5:00 am by alath
By Aparajita Lath The Truth Pill, authored by Dinesh Thakur and Prashant Reddy, is a monumental work that convincingly shows that drug regulation is but a myth in India. [read post]
31 Oct 2022, 5:00 am by alath
By Aparajita Lath Some COVID-19 vaccine manufacturers in the US have refused to share vaccine samples for research purposes, creating an access issue with the potential to delay comparator studies, follow-on research, and new vaccine / drug development. [read post]
17 Oct 2022, 9:00 am by alath
By Aparajita Lath The Supreme Court of India recently ruled that all women, whether married or not, have equal rights to access abortion up to 24 weeks of gestation, in compliance with the provisions of the Medical Termination of Pregnancy Act, 1971 (MTP Act). [read post]
30 Sep 2022, 12:40 pm by alath
By Aparajita Lath Indian lawmakers are currently debating proposed amendments that would make it easier for foreign investors to research and develop products from native biological resources, such as plants. [read post]
9 Sep 2013, 9:23 am by Shamnad Basheer
In a belated post (and a severely belated one at that), we bring you this special report on a conference held last year in Kolkata titled ‘Copyright Amendments, 2012: A Fair Balance? [read post]
23 May 2013, 2:06 pm by Joe Patrice
Sure, but… Continue reading »Follow Above the Law on Twitter or become a fan on Facebook.Tags: Aparajita Lath, Brian McCarthy, Connecticut, Defamation, DIsney, Education / Schools, India, Kirkland & Ellis, Latham & Watkins, Law Schools, Lucasfilm, Non-Sequiturs, Politics, Roy Cho, Silver Golub & Teitell, Skadden, Skadden Arps, Sri Srinivasan, Times Publishing House, Zachary Cohn     [read post]
2 Apr 2013, 10:33 am by Anubha Sinha
 Aparajita Lath wrote about the reference (order available here) made to a Full Bench of the Delhi High Court under the case Reckitt Benkiser India Ltd. v. [read post]
18 Mar 2013, 3:12 am by Anubha Sinha
 Aparajita Lath wrote an extensive post on the copyright controversy surrounding the movie remake of Zanjeer. [read post]
11 Feb 2013, 7:52 pm by L. Gopika
The week began with a two part post by Aparajita Lath on the impact of the digitization of content on the television, film and music industries. [read post]
29 Jan 2013, 10:44 am by Shouvik Kumar Guha
Aparajita Lath, another applicant, started her fellowship contention strongly with an incisive post on business method patents, the manner in which they are still being granted in India subverting the express statutory exclusion of the same and the policy considerations involved therein. [read post]
24 Jan 2013, 5:00 pm by Swaraj Paul Barooah
Aparajita Lath brings us her third submission to our SpicyIP Fellowship applicant series. [read post]
22 Jan 2013, 1:10 pm by Swaraj Paul Barooah
Aparajita Lath, a 3rd year student from NUJS, brings us this incisive guest post on Business Method Patents in India. [read post]